The numbers of cancer cells at SDF-1α-releasing HA implant site reduced substantially (~70%) at Day 2, increased slightly at Day 3 (estimated 31,000 KD cells/implant site), and then reduced with time (Fig. 4B). The gene discussed is CXCL12; the disease is cancer.